Results 211 to 220 of about 420,474 (296)

Stress History Establishes a Transient Tolerant State That Shapes Antibiotic Survival Upon Resuscitation

Advanced Science, EarlyView.
High‐throughput single‐cell analysis of resuscitating bacteria reveals a starvation‐history‐dependent transiently tolerant subpopulation that survives β$\beta$‐lactam exposure by temporarily reducing growth. Distinct from classical persisters, these actively growing yet dynamically modulated cells dominate survival across clinically relevant antibiotic
Kieran Abbott, Georgeos Hardo, Ruizhe Li, Jack Bradley, Ashraf Zarkan, Somenath Bakshi   +5 more
wiley   +1 more source

Reducing Youth Legal System Involvement: Updates From the Field and a Call to Action. [PDF]

Acad Pediatr
Tolliver DG, Goemann MC, Abrams LS, Meza BPL, Schickedanz A, Bath E, Heard-Garris N, Barnert E.   +7 more
europepmc   +1 more source

Effusion Reduction after Early Trastuzumab Deruxtecan Therapy for Unresectable HER2-Low Breast Cancer in an Older Patient: A Case Report. [PDF]

Surg Case Rep
Akabane A, Kawai M, Suzuki K, Goto A, Tanaka T, Futakuchi M, Motoi F.   +6 more
europepmc   +1 more source

The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta-analysis. [PDF]

Cancer
Ma Y, Li X, Jiang Y, Xiao L, Sun T.
europepmc   +1 more source

Revolutionizing HER2-Positive Breast Cancer Treatment: Insights from the 47th San Antonio Breast Cancer Symposium on Trastuzumab Deruxtecan. [PDF]

Asian Pac J Cancer Prev
Negahi A, Negahban H, Sayyad S, Khosravi-Mashizi M, Alijanpour A, Neamatzadeh H.   +5 more
europepmc   +1 more source

Facilitators to doctoral completion among international students in a Global South University: An appreciative inquiry perspective. [PDF]

PLoS One
Zhang S, Zhan H.
europepmc   +1 more source

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer. [PDF]

Clin Cancer Res
Jhaveri K, Loi S, Hamilton E, Schmid P, Anders CK, Testa L, Wildiers H, Tseng LM, Lu YS, Park YH, Im SA, Chen SC, Young RR, Lloyd C, Wrona M, Zhang C, Carroll D, André F.   +17 more
europepmc   +1 more source